We are live on ! Find out more
PCM

Pentwater Capital Management Portfolio holdings

AUM $19.3B
1-Year Est. Return 58.13%
This Fund
S&P 500
This Quarter Est. Return
+2.72%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$3.61B
AUM Growth
-$1.09B
Cap. Flow
-$1.24B
Cap. Flow %
-34.43%
Top 10 Hldgs %
58.4%
Holding
148
New
48
Increased
25
Reduced
29
Closed
30

Sector Composition

Rank Sector Weight
1 Healthcare 12.23%
2 Industrials 7.29%
3 Materials 6.06%
4 Consumer Discretionary 2.93%
5 Financials 2.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FON
76
CALL
DELISTED
SPRINT CORP FON COM
FON
$3.11M 0.09%
+500,000
New +$3.11M
FON
77
PUT
DELISTED
SPRINT CORP FON COM
FON
$3.11M 0.09%
500,000
-5,078,200
-91% -$31.6M
MBFI
78
DELISTED
MB Financial Corp
MBFI
$3.05M 0.08%
+107,975
New +$3.04M
TSLA icon
79
PUT
Tesla
TSLA
$1.27T
$2.9M 0.08%
225,000
-495,000
-69% -$4.9M
PFE icon
80
PUT
Pfizer
PFE
$147B
$2.87M 0.08%
105,400
-105,400
-50% -$2.87M
VVUS
81
DELISTED
Vivus Inc
VVUS
$2.79M 0.08%
30,000
+6,000
+25% +$749K
VVUS
82
PUT
DELISTED
Vivus Inc
VVUS
$2.79M 0.08%
+30,000
New +$3.75M
GM icon
83
General Motors
GM
$78.2B
$2.76M 0.08%
+76,704
New +$2.75M
SCR
84
DELISTED
SIMCERE PHARMACEUTICAL GROUP, ADS
SCR
$2.58M 0.07%
272,209
+19,536
+8% +$185K
CLVS
85
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$2.43M 0.07%
+40,000
New +$2.84M
BAC icon
86
Bank of America
BAC
$442B
$2.28M 0.06%
165,000
CSTM icon
87
Constellium
CSTM
$4.02B
$2.05M 0.06%
105,800
-383,777
-78% -$6.98M
BMRN icon
88
BioMarin Pharmaceuticals
BMRN
$11.6B
$1.99M 0.05%
+27,500
New +$1.83M
GS icon
89
Goldman Sachs
GS
$313B
$1.9M 0.05%
12,000
EQC
90
DELISTED
Equity Commonwealth
EQC
$1.86M 0.05%
85,000
-15,000
-15% -$357K
WLH
91
DELISTED
WILLIAM LYON HOMES
WLH
$1.76M 0.05%
86,712
+1,000
+1% +$22.1K
CUBI icon
92
Customers Bancorp
CUBI
$2.8B
$1.63M 0.05%
111,356
-2,860
-3% -$43.5K
OPK icon
93
Opko Health
OPK
$1.01B
$1.54M 0.04%
+174,874
New +$1.4M
BCC icon
94
Boise Cascade
BCC
$2.98B
$1.52M 0.04%
+56,555
New +$1.45M
BMRN icon
95
PUT
BioMarin Pharmaceuticals
BMRN
$11.6B
$1.44M 0.04%
+20,000
New +$1.33M
ANR
96
DELISTED
Alpha Natural Resources Inc
ANR
$1.07M 0.03%
180,000
EBIX
97
PUT
DELISTED
Ebix Inc
EBIX
$994K 0.03%
+100,000
New +$1.09M
JCP
98
PUT
DELISTED
J.C. Penney Company, Inc.
JCP
$881K 0.02%
+100,000
New +$1.43M
XONE
99
DELISTED
The ExOne Company
XONE
$852K 0.02%
+20,000
New +$1.25M
HLF icon
100
Herbalife
HLF
$1.31B
$823K 0.02%
+23,598
New +$730K

Similar funds

Pentwater Capital Management's Q3 2013 Portfolio in Review

As of Q3 2013, Pentwater Capital Management held 148 positions worth $3.61B, down 23% from $4.71B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Pentwater Capital Management withdrew a net $1.24B in Q3 2013, closing 30 positions and reducing 29 holdings. Its most notable exit was Pfizer, an estimated $783M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 28% a quarter earlier, followed by Industrials and Materials.

Against the trend, Pentwater Capital Management opened a new position in Cooper Tire & Rubber Co. worth $70.8M.

  • Pentwater Capital Management's largest Q3 2013 buy was Cooper Tire & Rubber Co.: 2,300,000 shares worth $70.8M.
  • Pentwater Capital Management added most to LENDER PROCESSING SERVICES INC in Q3 2013, an estimated $112M increase.
  • Pentwater Capital Management's biggest Q3 2013 reduction was Zoetis, cutting an estimated $257M.
  • Pentwater Capital Management fully exited Pfizer in Q3 2013, selling an estimated $783M.
  • Pentwater Capital Management's ten largest holdings make up 58% of its $3.61B portfolio in Q3 2013.
  • Pentwater Capital Management opened 48 new positions and closed 30 in Q3 2013.
  • Pentwater Capital Management's portfolio value fell 23% quarter-over-quarter to $3.61B.

Based on Pentwater Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.